Clinical Trial: A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07037901) titled 'A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis' on June 17.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis Atopic Dermatitis Eczema Eczema

Intervention: DRUG: IMG-007

Participants will receive IMG-007 subcutaneously.

DRUG: Placebo

Participants will receive a placebo subcutaneously.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Inmagene LLC

Disclaimer: Curated by HT Syndicat...